Skip to content

Amiel Shrchaton

Shamir Research Institute, University of Haifa, P.O. Box 97, Qatzrin 1290000, Israel.

1 paper in the library · 11 citations · publishing 2025

Papers

Exploring Psilocybe cubensis Strains: Cultivation Techniques, Psychoactive Compounds, Genetics and Research Gaps

Journal of Fungi January 28, 2025 Eyal Kurzbaum, Tomáš Páleníček, Amiel Shrchaton et al. 11 citations

The psychoactive mushroom Psilocybe cubensis, known for its historical and modern therapeutic roles, shows substantial variability in its psychoactive compounds, psilocybin and psilocin, due to genetic diversity, strain differences, and environmental factors. Advances in cultivation, such as submerged fermentation of mycelium, and improved analytical methods now allow more precise compound quantification and extraction. Despite nearly four decades of regulatory restrictions limiting scientific information, recent genetic and biochemical studies are beginning to reveal insights into its therapeutic potential. The review identifies key knowledge gaps and suggests future research directions to improve cultivation, document strain diversity, and address regulatory and therapeutic uses.